J Neurol Surg B Skull Base 2025; 86(S 01): S1-S576
DOI: 10.1055/s-0045-1803045
Presentation Abstracts
Podium Presentations
Oral Presentations

Simplifying Inferior Petrosal Sinus Sampling: Results of a Multicenter Study

Paul Gardner
1   University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
,
Julie Silverstein
2   Washington University School of Medicine, United Sates
,
Albert Kim
2   Washington University School of Medicine, United Sates
,
James Evans
3   Jefferson University, Philadelphia, Pennsylvania, United States
,
Sarah Collopy
3   Jefferson University, Philadelphia, Pennsylvania, United States
,
Robert Rennert
4   University of Utah, Salt Lake City, Utah, United States
,
William Couldwell
4   University of Utah, Salt Lake City, Utah, United States
,
Garni Barkhoudarian
5   Pacific Neuroscience Institute, Santa Monica, California, United States
,
Dan Kelly
5   Pacific Neuroscience Institute, Santa Monica, California, United States
,
Juan Fernandez-Miranda
6   Stanford University, Stanford, California, United States
,
Donato Pacione
7   New York University, New York, New York, United States
,
Won Kim
8   University of California, Los Angeles, United States
,
Marvin Bergsneider
8   University of California, Los Angeles, United States
,
Michael Chicoine
9   University of Missouri, Columbia, Missouri, United States
,
Gabriel Zada
10   Keck School of Medicine, Los Angeles, California, United States
,
Varun Kshettry
11   Cleveland Clinic Foundation, Cleveland, Ohio, United Sates
,
Kyle Wu
12   Ohio State College of Medicine, Ohio State University, Columbus, Ohio, United States
,
Carolina Benjamin
13   University of Miami, Coral Gables, Florida, United States
,
Jamie Van Gompel
14   Mayo Clinic
,
Michael Catalino
15   University of Virginia, Charlottesville, Virginia, United States
,
Adam Mamelak
16   Cedars-Sinai Medical Center, Los Angeles, California, United Kingdom
,
Nathan Zwagerman
17   Medical College of Wisconsin, Wisconsin, United States
,
Andrew Little
18   Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
,
Kevin Yuen
18   Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
,
Ildiko Torok
18   Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
,
Michael Karsy
19   Drexel University College of Medicine, Philadelphia, Pennsylvania, United Sates
› Institutsangaben
 

Introduction: Inferior petrosal sinus sampling (IPSS) is an important method for confirming a central source and lateralization for adrenocorticotrophin (ACTH) secretion in Cushing’s disease (CD), though it is technically challenging requiring synchronized blood draws at numerous time points before and after stimulation We explored IPSS results from a multicenter experience to determine if it might be possible to decrease the number of blood draws and retain diagnostic utility.

Methods: Patients from the Registry of Adenomas of the PItuitary and Related Disorders (RAPID) who underwent IPSS for management of CD were included. An analysis of surgical characteristics and laboratory values as well as stimulation protocols and response was performed. Lateralized IPSS ACTH levels with the highest values were normalized to peripheral levels.

Results: Of the 780 patients who were included, 108 underwent IPSS. No differences in baseline characteristics were seen but a higher number of patients with IPSS had MRI-negative disease (81.8 vs. 66.1%, p = 0.02) and long-term remission (71.9 vs. 57.8%, p = 0.01). Among patients with IPSS, 93/108 (86.11%) demonstrated positive pathology or long-term disease remission. Stimulation paradigms showed a 5.0-, 4.6-, and 4.2-fold increase in IPSS ACTH at 2, 5, and 10 minutes poststimulation at the lateralized side of IPSS sampling compared with nonlateralized side, respectively. A 2.4-fold increase in IPSS at the localized side compared with baseline was seen at 2 minutes poststimulation. Both corticotrophin releasing hormone (CRH) and desmopressin (DDAVP) showed best response in ACTH levels around 2 to 5 minutes poststimulation. Patients with long-term remission showed a greater stimulation response also at 2 to 5 minutes compared with those who did not have long-term remission or positive pathology.

Discussion: Pituitary teams can use these data suggesting that stimulation responses of 2.4× from baseline at 2 minutes can indicate a positive response. A four to five times difference between 2 and 10 minutes was seen in lateralizing ACTH responses. These results may help with reducing testing burden on patients and decrease the complexity of the test.

Zoom
Fig. 1 Normalized ACTH levels during IPSS for localized and nonlocalized sides.
Zoom
Fig. 2 Normalized ACTH to PRL levels during IPSS for localized and nonlocalized sides.
Zoom
Fig. 3 Normalized ACTH levels for DDAVP vs. CRH stimulation during IPSS for localized and nonlocalized sides.
Zoom
Fig. 4 Normalized ACTH levels for patients with and without remission/pathology during IPSS for localized and nonlocalize sides.


Publikationsverlauf

Artikel online veröffentlicht:
07. Februar 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany